Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)

NCT01005056 · clinicaltrials.gov ↗

COMPLETED

Status

3838

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: Ethinylestradiol + Desogestrel

Sponsor

Organon and Co